Muscle Cramps and Neuropathies in Patients with Allogeneic Hematopoietic Stem Cell Transplantation and Graft-versus-Host Disease

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Kraus, Peter D ^a   Wolff, Daniel ^a   Grauer, Oliver ^a,e   Angstwurm, Klemens ^a   Jarius, Sven ^b   Wandinger, Klaus P ^c   Holler, Ernst ^a   Schulte Mattler, Wilhelm ^a   Kleiter, Ingo ^d  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Affiliated to Euroimmun   (Germany)

^d ST JOSEF HOSPITAL   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; MITOCHONDRION ANTIBODY; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBODY DETECTION; ARTICLE; AXONAL POLYNEUROPATHY; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; DAILY LIFE ACTIVITY; DEMYELINATING NEUROPATHY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ELECTROMYOGRAPHY; FEMALE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; MALE; MUSCLE CRAMP; MYOPATHY; MYOSITIS; ONSET AGE; PAIN ASSESSMENT; POLYNEUROPATHY; RETROSPECTIVE STUDY; SLEEP QUALITY; TIBIAL NERVE;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOLOGIC TESTS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MUSCLE CRAMP; POLYNEUROPATHIES; RETROSPECTIVE STUDIES; SEROLOGIC TESTS; TACROLIMUS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84866466586     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044922     Document Type: Article

References (43)

1. Ferrara JL, Levine JE, Reddy P, Holler E, (2009) Graft-versus-host disease. Lancet 373: 1550-1561.
2. Shlomchik WD, (2007) Graft-versus-host disease. Nat Rev Immunol 7: 340-352.
3. Blazar BR, Murphy WJ, Abedi M, (2012) Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol 12: 443-458.
4. Wolff D, Gerbitz A, Ayuk F, Kiani A, Hildebrandt GC, et al. (2010) Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD. Biol Blood Marrow Transplant 16: 1611-1628.
5. Wolff D, Schleuning M, von Harsdorf S, Bacher U, Gerbitz A, et al. (2010) Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant 17: 1-17.
6. Grauer O, Wolff D, Bertz H, Greinix H, Kuhl JS, et al. (2010) Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease. Brain 133: 2852-2865.
7. Openshaw H (2009) Neurological Manifestations of Chronic Graft versus Host Disease. In: Vogelsang GB, Pavletic SZ, editors. Chronic Graft versus Host Disease. New York: Cambridge University Press 243-251.
8. Openshaw H, (1997) Peripheral neuropathy after bone marrow transplantation. Biol Blood Marrow Transplant 3: 202-209.
9. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, et al. (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11: 945-956.
10. Wen PY, Alyea EP, Simon D, Herbst RS, Soiffer RJ, et al. (1997) Guillain-Barre syndrome following allogeneic bone marrow transplantation. Neurology 49: 1711-1714.
11. Thöne J, Lamprecht S, Hohaus A, Erbguth F, Bickel A, (2010) Guillain-Barre syndrome as leading manifestation of graft-versus-host disease in an allogeneic bone marrow transplanted patient. J Neurol Sci 292: 114-116.
12. Lorenzoni PJ, Scola RH, Carsten AL, Trentin AP, Teive HA, et al. (2007) Chronic inflammatory demyelinating polyradiculoneuropathy in chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: case report. Arq Neuropsiquiatr 65: 700-704.
13. Wada S, Kimura T, Ikegame K, Kajiyama K, Takeda M, et al. (2008) [Chronic inflammatory demyelinating polyradiculoneuropathy and hyponatremia in a patient with chronic graft versus host disease]. Rinsho Shinkeigaku 48: 426-429.
14. Mulrooney DA, Davies SM, Walk D, Charnas LR, (2003) Late occurrence of chronic immune-mediated axonal polyneuropathy following bone marrow transplant for juvenile-onset alpha-mannosidosis. Bone Marrow Transplant 32: 953-955.
15. Amato AA, Barohn RJ, Sahenk Z, Tutschka PJ, Mendell JR, (1993) Polyneuropathy complicating bone marrow and solid organ transplantation. Neurology 43: 1513-1518.
16. Sostak P, Padovan CS, Yousry TA, Ledderose G, Kolb HJ, et al. (2003) Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology 60: 842-848.
17. Suzuki S, Mori T, Mihara A, Aisa Y, Ikeda Y, et al. (2007) Immune-mediated motor polyneuropathy after hematopoietic stem cell transplantation. Bone Marrow Transplant 40: 289-291.
18. Miller TM, Layzer RB, (2005) Muscle cramps. Muscle Nerve 32: 431-442.
19. Rubio-Agusti I, Perez-Miralles F, Sevilla T, Muelas N, Chumillas MJ, et al. (2011) Peripheral nerve hyperexcitability: a clinical and immunologic study of 38 patients. Neurology 76: 172-178.
20. Herzberg PY, Heussner P, Mumm FH, Horak M, Hilgendorf I, et al. (2010) Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 16: 1707-1717.
21. Mumm F, Herzberg P, von Harsdorf S, Gerbitz A, Greinix H, et al. (2008) Severity of chronic GVHD correlates with comorbidities, physical functioning, and quality of life - results of an interim analysis of the German Multicenter Validation Trial. Onkologie 31: 46.
22. Pavletic SZ, Martin P, Lee SJ, Mitchell S, Jacobsohn D, et al. (2006) Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant 12: 252-266.
23. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, et al. (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15: 825-828.
24. Heuß D, Auer-Grumbach M, Haupt F, Löscher W, Neundörfer B, et al. (2008) Diagnostik bei Polyneuropathien. In: Diener HC, Putzki N, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Thieme.
25. Busch V, Schulte-Mattler WJ, (2010) Differentiation between uniform and non-uniform motor nerve conduction slowing. Clin Neurophysiol 121: 890-894.
26. Schulte-Mattler WJ, Jakob M, Zierz S, (1999) Assessment of temporal dispersion in motor nerves with normal conduction velocity. Clin Neurophysiol 110: 740-747.
27. Schulte-Mattler WJ (2006) Conduction velocity distribution. In: Kimura J, editor. Neurophysiology of Peripheral Nerve Diseases Handbook of Clinical Neurophysiology Series. Amsterdam: Elsevier. 405-419.
28. Van der Meche FG, Van Doorn PA, Meulstee J, Jennekens FG, (2001) Diagnostic and classification criteria for the Guillain-Barre syndrome. Eur Neurol 45: 133-139.
29. Van den Bergh PY, Hadden RD, Bouche P, Cornblath DR, Hahn A, et al. (2010) European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society- first revision. Eur J Neurol 17: 356-363.
30. Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, et al. (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 133: 2734-2748.
31. Padovan CS, Yousry TA, Schleuning M, Holler E, Kolb HJ, et al. (1998) Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation. Ann Neurol 43: 627-633.
32. Barba P, Pinana JL, Valcarcel D, Querol L, Martino R, et al. (2009) Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation. Biol Blood Marrow Transplant 15: 1439-1446.
33. Rabinstein AA, Dispenzieri A, Micallef IN, Inwards DJ, Litzow MR, et al. (2003) Acute neuropathies after peripheral blood stem cell and bone marrow transplantation. Muscle Nerve 28: 733-736.
34. Padovan CS, Sostak P, Reich P, Kolb HJ, Muller-Felber W, et al. (2003) Neuromuskuläre Komplikationen nach allogener Knochenmarktransplantation. Nervenarzt 74: 159-166.
35. Fujisaki G, Kami M, Murashige N, Kishi Y, Hori A, et al. (2006) Guillain-Barre syndrome associated with rapid immune reconstitution following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 37: 617-619.
36. Eliashiv S, Brenner T, Abramsky O, Shahin R, Agai E, et al. (1991) Acute inflammatory demyelinating polyneuropathy following bone marrow transplantation. Bone Marrow Transplant 8: 315-317.
37. Bulsara KR, Baron PW, Tuttle-Newhall JE, Clavien PA, Morgenlander J, (2001) Guillain-Barre syndrome in organ and bone marrow transplant patients. Transplantation 71: 1169-1172.
38. Gabriel CM, Goldman JM, Lucas S, Hughes RA, (1999) Vasculitic neuropathy in association with chronic graft-versus-host disease. J Neurol Sci 168: 68-70.
39. Nagashima T, Sato F, Chuma T, Mano Y, Sasaki I, et al. (2002) Chronic demyelinating polyneuropathy in graft-versus-host disease following allogeneic bone marrow transplantation. Neuropathology 22: 1-8.
40. Greenspan A, Deeg HJ, Cottler-Fox M, Sirdofski M, Spitzer TR, et al. (1990) Incapacitating peripheral neuropathy as a manifestation of chronic graft-versus-host disease. Bone Marrow Transplant 5: 349-352.
41. Layzer RB, (1994) The origin of muscle fasciculations and cramps. Muscle Nerve 17: 1243-1249.
42. Miklos DB, Kim HT, Miller KH, Guo L, Zorn E, et al. (2005) Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood 105: 2973-2978.
43. Reiber H, (1994) Flow rate of cerebrospinal fluid (CSF)- a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci 122: 189-203.